Kiromic BioPharma, Inc. - stock earnings
KRBP Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -4.2 million USD | ? USD |
2023Q2 | -6.8 million USD | ? USD |
2023Q1 | -7.1 million USD | ? USD |
2022Q4 | -7.1 million USD | ? USD |
2022Q3 | -15.3 million USD | ? USD |
2022Q2 | -8.4 million USD | ? USD |
2022Q1 | -10.6 million USD | ? USD |
2021Q4 | -6.1 million USD | ? USD |
2021Q3 | -6.1 million USD | ? USD |
2021Q2 | -5.0 million USD | ? USD |
2021Q1 | -3.9 million USD | ? USD |
2020Q4 | -3.6 million USD | ? USD |
2020Q3 | -2.4 million USD | ? USD |
2020Q2 | -11.4 million USD | ? USD |
2020Q1 | -1.9 million USD | ? USD |
2019Q4 | -2.2 million USD | ? USD |
2019Q3 | -886900 USD | ? USD |
2019Q2 | -280400 USD | ? USD |
2019Q1 | -390900 USD | ? USD |
KRBP Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2022 | -38.2 million USD | ? USD |
2021 | -25.7 million USD | ? USD |
2020 | -19.2 million USD | ? USD |
2019 | -3.8 million USD | ? USD |
2018 | -3.8 million USD | ? USD |
KRBP
Price: $2.44
52 week price:
Earnings Per Share: -12.59 USD
P/E Ratio: -0.07
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 1.8 million
Market Capitalization: 3.8 million